
Petin 37.5mg Tablet CR
Marketer
Molekule India Pvt Ltd
Salt Composition
Paroxetine (37.5mg)
Overview Petin 37.5mg Tablet CR
Sertraline 37.5mg extended-release tablets are an antidepressant medication classified as a selective serotonin reuptake inhibitor (SSRI). Frequently prescribed for depression and anxiety disorders, including obsessive-compulsive disorder and panic attacks, this medication helps alleviate symptoms by improving mood and reducing anxiety. It can be administered with or without food. Dosage and frequency are determined by your physician to effectively manage your condition, often starting with a lower dose gradually increased. Never adjust or discontinue treatment without consulting your doctor; abrupt cessation may worsen symptoms or trigger withdrawal effects such as restlessness, anxiety, palpitations, dizziness, sleep disturbances, and others. For optimal results, take this medication consistently at the same time daily, potentially in the morning if sleep disturbances occur. Improvement may take several weeks. Report a lack of progress after four weeks of treatment. Common side effects include nausea, tiredness, dry mouth, appetite changes, increased perspiration, dizziness, nervousness, tremors, insomnia, and constipation. Reduced libido, delayed ejaculation, and erectile dysfunction are also possible. Immediately inform your doctor of any sudden mood changes or suicidal thoughts. Prior to starting this treatment, inform your physician about epilepsy, diabetes, liver or kidney impairment, heart conditions, or glaucoma, as these can impact treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Interactions with other medications, particularly other antidepressants and MAO inhibitors, may occur, so provide your doctor with a complete list of all medications you are currently taking.
Primary Ingredients of Petin 37.5mg Tablet CR
No information provided. Please provide the text you wish to be rephrased.
Uses of Petin 37.5mg Tablet CR
Managing Depressive Disorders | Addressing Panic Attacks | Coping with Anxiety
Major Benefits of Petin 37.5mg Tablet CR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Petin 37.5mg Tablet CR can be consumed with or without food, though consistent daily timing is recommended.
Common Side effects of Petin 37.5mg Tablet CR:
- Nausea
- Fatigue
- Dryness in mouth
- Loss of appetite
- Increased sweating
- Dizziness
- Nervousness
- Tremors
- Low sexual desire
- Insomnia (difficulty in sleeping)
- Confusion
- Constipation
- Erectile dysfunction
- Delayed ejaculation
- Decreased libido
How to use Petin 37.5mg Tablet CR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Petin 37.5mg Controlled-Release Tablets can be consumed with or without food, though consistent timing is recommended.
How Petin 37.5mg Tablet CR works:
Petin 37.5mg Controlled-Release tablets are an SSRI antidepressant that elevates serotonin, a neurotransmitter crucial for mood regulation. This mechanism alleviates depressive symptoms, both emotional and physical, and also offers relief from panic attacks, anxiety, and obsessive-compulsive disorder.
SAFETY ADVICE
AlcoholUNSAFE
Combining Petin 37.5mg Tablet CR and alcohol is unsafe.
PregnancyUNSAFE
The use of Petin 37.5mg Tablet CR is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animal and human subjects indicates substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Petin 37.5mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Extended-release Petin 37.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Petin 37.5mg Tablet CR cautiously; dosage modification may be necessary. Seek medical advice.
LiverCAUTION
Patients with liver impairment should exercise caution when using Petin 37.5mg Controlled-Release tablets. Dosage modification of Petin 37.5mg Controlled-Release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Petin 37.5mg Tablet CR :
Should you forget a Petin 37.5mg CR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Petin 37.5mg Tablet CR
| Label | Value |
|---|---|
| Chemical Category | Phenylpiperidine analog |
| Developing Good Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Behavioral Class | Selective serotonin reuptake inhibitors (SSRIs) |
